TrialJournal of the National Cancer Institute2016

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

Amir Sonnenblick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.